Journal: EMBO Reports
Article Title: TIFA has dual functions in Helicobacter pylori ‐induced classical and alternative NF‐κB pathways
doi: 10.15252/embr.202152878
Figure Lengend Snippet: A Parental AGS, ALPK1‐KO, and TIFA‐KO cells were infected with H. pylori for the times shown. Total cell lysates were analyzed by immunoblotting using the indicated antibodies. CagA demonstrated a similar infection rate of the different cells. Asterisk denotes an unspecific band and the arrow indicates the band corresponding to phosphorylated p100. B Total RNA was isolated from ALPK1‐KO cells and analyzed using quantitative RT‐PCR for the ALPK1 transcript. Data shown depict the average of triplicate determinations normalized to the RPL13A housekeeping gene. Error bars denote RQ ± RQ min /RQ max . C TIFA‐KO cells were transfected with His‐tagged recombinant TIFA protein 24 h prior to H. pylori infection. Co‐IP with an anti‐His antibody was performed. Eluates and total cell lysates were analyzed by immunoblotting using the indicated antibodies. Asterisk denotes an unspecific band and the arrow indicates the TRAF2 band. D, E AGS and ALPK1‐KO (D) or TIFA‐KO (E) cells were infected with H. pylori for the times shown. Co‐IP with an anti‐TRAF6 antibody or isotype‐matched antibody (IgG) was performed. Eluates and total cell lysates were analyzed by immunoblotting using the indicated antibodies. F AGS and TIFA‐KO cells were treated with 30 ng/ml IL‐1β for the times shown. Co‐IP with an anti‐TRAF6 antibody or isotype‐matched antibody (IgG) was performed. Eluates and total cell lysates were analyzed by immunoblotting using the indicated antibodies. Data information: Data shown (A, C‐F) are representative for at least two independent experiments. GAPDH served as loading control. Data shown in (B) are from one experiment with three technical repeats. Source data are available online for this figure.
Article Snippet: The following primary antibodies were used: GAPDH (Millipore, #MAB374); CagA (Austral Biologicals, #HPM‐5001‐5); Flagellin (Acris, AM00865PU‐N); C23 (sc‐13057), A20 (sc‐166692), RelA (sc‐8008), RelB (sc‐226), cIAP1 (sc‐271419, for denaturing IP), TRAF2 (sc‐136999), and His‐probe (sc‐804) were purchased from Santa Cruz Biotechnology; phospho‐IκBα (#9246), IκBα (#4812), phospho‐RelA (#3031), phospho‐p38 (#4511), p38 (#9212), phospho‐SAPK/JNK (#4671), phospho‐p44/42 (Erk1/2) (#4377), phospho‐p100 (#4810), phospho‐TAK1 (#4508), NIK (#4994), TIFA (#61358), TAK1 (#5206), TRAF6 (#8028), SAPK/JNK (#9252), cIAP1 (#7065), cIAP2 (#3130), p44/42 MAPK (Erk1/2) (#4696), and p100/p52 (#4882) were purchased from Cell Signaling Technology.
Techniques: Infection, Western Blot, Isolation, Quantitative RT-PCR, Transfection, Recombinant, Co-Immunoprecipitation Assay